Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review

被引:32
作者
Dupre, Anastasia [1 ]
Michot, Jean-Marie [2 ]
Schoeffler, Amelie [3 ]
Frumholtz, Laure [4 ]
Baroudjian, Barouyr [4 ]
Delyon, Julie [4 ,5 ]
Lebbe, Celeste [4 ,5 ]
Lambotte, Olivier [1 ,6 ]
机构
[1] Univ Paris Saclay, Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Paris, France
[2] Gustave Roussy, DITEP, Villejuif, France
[3] CHR Metz Thionville, Serv Dermatol, Paris, France
[4] Hop St Louis, AP HP, Serv Dermatol, Paris, France
[5] Univ Paris, St Louis Hosp, AP HP, INSERM,U976,Dermatol, Paris, France
[6] Univ Paris Saclay, INSERM, CEA, Ctr Rech Immunol Infect Virales & Malad Autoimmun, Le Kremlin Bicetre, France
关键词
tumour immunotherapy; haemophagocytic lymphohistiocytosis; haematotoxicity; BLOCKADE;
D O I
10.1111/bjh.16630
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:985 / 992
页数:8
相关论文
共 9 条
[1]   Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the PRF1A91V gene polymorphism [J].
Al-Samkari, Hanny ;
Snyder, Gregory D. ;
Nikiforow, Sarah ;
Tolaney, Sara M. ;
Freedman, Rachel A. ;
Losman, Julie-Aurore .
JOURNAL OF MEDICAL GENETICS, 2019, 56 (01) :39-42
[2]   Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome [J].
Fardet, Laurence ;
Galicier, Lionel ;
Lambotte, Olivier ;
Marzac, Christophe ;
Aumont, Cedric ;
Chahwan, Doumit ;
Coppo, Paul ;
Hejblum, Gilles .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2613-2620
[3]   Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors [J].
Hargadon, Kristian M. ;
Johnson, Coleman E. ;
Williams, Corey J. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 :29-39
[4]   Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH [J].
Hayden, Anna ;
Lin, Molly ;
Park, Sujin ;
Pudek, Morris ;
Schneider, Marion ;
Jordan, Michael B. ;
Mattman, Andre ;
Chen, Luke Y. C. .
BLOOD ADVANCES, 2017, 1 (26) :2529-2534
[5]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[6]   Recommendations for the management of hemophagocytic lymphohistiocytosis in adults [J].
La Rosee, Paul ;
Horne, AnnaCarin ;
Hines, Melissa ;
Greenwood, Tatiana von Bahr ;
Machowicz, Rafal ;
Berliner, Nancy ;
Birndt, Sebastian ;
Gil-Herrera, Juana ;
Girschikofsky, Michael ;
Jordan, Michael B. ;
Kumar, Ashish ;
van Laar, Jan A. M. ;
Lachmann, Gunnar ;
Nichols, Kim E. ;
Ramanan, Athimalaipet, V ;
Wang, Yini ;
Wang, Zhao ;
Janka, Gritta ;
Henter, Jan-Inge .
BLOOD, 2019, 133 (23) :2465-2477
[7]   Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults [J].
Liu, Pengpeng ;
Pan, Xiangyu ;
Chen, Chong ;
Niu, Ting ;
Shuai, Xiao ;
Wang, Jian ;
Chen, Xuelan ;
Liu, Jiazhuo ;
Guo, Yong ;
Xie, Liping ;
Wu, Yu ;
Liu, Yu ;
Liu, Ting .
BLOOD, 2020, 135 (11) :826-833
[8]   Immune-related adverse events with immune checkpoint blockade: a comprehensive review [J].
Michot, J. M. ;
Bigenwald, C. ;
Champiat, S. ;
Collins, M. ;
Carbonnel, F. ;
Postel-Vinay, S. ;
Berdelou, A. ;
Varga, A. ;
Bahleda, R. ;
Hollebecque, A. ;
Massard, C. ;
Fuerea, A. ;
Ribrag, V. ;
Gazzah, A. ;
Armand, J. P. ;
Amellal, N. ;
Angevin, E. ;
Noel, N. ;
Boutros, C. ;
Mateus, C. ;
Robert, C. ;
Soria, J. C. ;
Marabelle, A. ;
Lambotte, O. .
EUROPEAN JOURNAL OF CANCER, 2016, 54 :139-148
[9]   Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis [J].
Parikh, Sameer A. ;
Kapoor, Prashant ;
Letendre, Louis ;
Kumar, Shaji ;
Wolanskyj, Alexandra P. .
MAYO CLINIC PROCEEDINGS, 2014, 89 (04) :484-492